The Lite Strategy Litecoin treasury reached 929,548 LTC by September 30, 2025, according to the company's first quarter fiscal year 2026 results. That makes Lite Strategy the first and only US publicly traded company to gain institutional exposure to Litecoin at scale. The results, reported November 17, 2025, mark the company's transformation from a pharmaceutical business into a digital asset treasury operator.
From MEI Pharma to Lite Strategy
The company, trading on NASDAQ as LITS, recently rebranded from MEI Pharma, changing both its corporate name and ticker symbol from MEIP to LITS, alongside a new corporate logo and website. That rebrand followed the sale of the company's clinical asset ME-344, now known as WE-868, currently being developed for adults with obesity at Aardvark Therapeutics. CEO and CFO Jay File described this as a step reshaping the company's direction ahead of its shift into digital assets.
How the $100 Million Treasury Strategy Got Funded
The Litecoin treasury strategy was funded through a $100 million PIPE (private investment in public equity) financing completed in July 2025. That laid the groundwork for launching the digital asset treasury program in the first quarter of fiscal year 2026. Throughout the quarter, Lite Strategy raised $100 million in aggregate gross proceeds and began deploying that capital into Litecoin as its primary reserve asset.
Governance and Strategic Partnerships
Lite Strategy brought on notable board members to guide the transition, including Charlie Lee, the creator of Litecoin, and Joshua Riezman, US Chief Strategy Officer at GSR. The company also entered a strategic partnership with GSR, a crypto investment firm, to guide its digital asset treasury strategy with governance, execution, and market expertise. Charlie Lee stated the first quarter was incredibly successful for LITS. He noted the company launched its digital treasury strategy while positioning itself as the leading public holder of LTC.
Moving From Accumulation to Active Capital Market Operations
In October, Lite Strategy announced a $25 million share repurchase program. The company describes this move as advancing it from the initial phase of Litecoin accumulation into active capital market operations. This shift lets Lite Strategy leverage its nearly one million LTC treasury directly. The company positions this as a key structural differentiator from passive investment vehicles like exchange-traded funds, which can't actively manage their holdings in the same way.
What Happens to the Legacy Pharmaceutical Assets
Lite Strategy continues to evaluate its remaining clinical assets even as its primary focus shifts to digital assets. The company is commencing pre-clinical studies with voruciclib in non-oncology disease indications for potential third-party licensing, and pursuing licensing or sale opportunities for zandelisib. Jay File indicated that fiscal year 2026 will showcase the results of these transformative steps, following a strategic alternatives process that began in fiscal year 2025.
Litecoin's Track Record as a Treasury Asset
Charlie Lee referenced Litecoin's 14th anniversary and what he described as its unblemished track record of reliability and uptime as part of the rationale for choosing it as the company's primary reserve asset. He positioned LITS as offering investors a unique way to gain both portfolio diversification and long-term value exposure to Litecoin through a regulated, publicly traded vehicle.
Corporate digital asset treasury strategies like this reflect the same institutional-adoption trend seen in Kalshi's TRON integration. Both signal how regulated, publicly accountable entities are increasingly building direct exposure to blockchain assets and infrastructure.
The parallel is worth noting in iZUMi Finance Acquisition Gives CIMG DL-AMM Technology, which covers a related development from a different angle.
Glossary
- PIPE financing: Private Investment in Public Equity, a fundraising method where investors purchase shares of a publicly traded company directly, often at a discount, outside a public offering.
- Digital asset treasury strategy: A corporate approach where a company holds cryptocurrency as a primary reserve asset on its balance sheet, similar to how companies traditionally hold cash or bonds.
- Share repurchase program: A corporate initiative where a company buys back its own outstanding shares from the market, often to return value to shareholders or address a valuation gap.
Disclaimer
This overview is for informational purposes only and is not financial or investment advice. Corporate digital asset treasury strategies carry significant risk tied to cryptocurrency price volatility. Confirm current holdings and financial results directly through official Lite Strategy SEC filings and announcements.
